US2005031665A1PendingUtilityA1

Device and method for treating conditions of a joint

Priority: Nov 3, 2000Filed: Jun 23, 2004Published: Feb 10, 2005
Est. expiryNov 3, 2020(expired)· nominal 20-yr term from priority
A61K 9/0024A61L 31/16A61L 2300/222A61M 2210/02A61L 2300/602A61B 2017/00955A61F 2/30744A61B 17/0642A61M 31/002A61B 2017/00429A61F 2002/30673A61B 17/82A61B 17/80A61B 2017/00004A61B 17/8615A61B 17/8886A61B 2017/0648A61F 2002/30677A61B 17/8877A61B 2017/0647A61L 2300/416A61P 19/02A61B 17/1615
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A therapeutically effective compound is locally administered by associating the compound with a piece of orthopedic hardware that is implanted at an appropriate site within a body. The compound is adapted, such as through a sustained release device, to administer an effective dosage continuously over an extended period of time. The compound may be administered, for example, to a joint of a mammal by intraarticularly implanting a sustained release device to deliver the therapeutically effective compound within a synovial capsule of the joint, such that synovial fluid concentration of the compound is greater than plasma concentration of the compound. A wide range of orthopedic hardware, such as bone screws and staples, may be adapted to use in the systems described herein to provide treatment for a variety of medical conditions.

Claims

exact text as granted — not AI-modified
1 . A system comprising: 
 an orthopedic hardware component attachable to a portion of a body; and    a sustained release device associated with the orthopedic hardware component, the sustained release device configured to release a compound having a therapeutic effect over an extended period of time.    
     
     
         2 . The system of  claim 1  wherein the orthopedic hardware component is a bone screw.  
     
     
         3 . The system of  claim 2  wherein the bone screw includes a head, the sustained release device being formed in a chamber in the head.  
     
     
         4 . The system of  claim 2  wherein the bone screw is at least one of a cannulated bone screw and an interference bone screw.  
     
     
         5 . The system of  claim 1  wherein the orthopedic hardware component is at least one of a staple, a tack, a dart, a screw, a bolt, a washer, a plate, a prosthetic joint, a component of a prosthetic joint, an anchor, a pin, a wire, or a button.  
     
     
         6 . The system of  claim 1  wherein the orthopedic hardware component is substantially rigid and is configured for at least partial insertion into a bone.  
     
     
         7 . The system of  claim 1  wherein the sustained release device is removably associated with the orthopedic hardware component.  
     
     
         8 . The system of  claim 7  wherein the sustained release device is threaded to the orthopedic hardware component such that the sustained release device is rotatably removable from and replaceable to the orthopedic hardware component.  
     
     
         9 . The system of  claim 8  wherein the sustained release device is a cap threaded to an outward projecting surface of the orthopedic hardware component.  
     
     
         10 . The system of  claim 8  wherein the sustained release device is a screw threaded to an inwardly projecting surface of the orthopedic hardware component.  
     
     
         11 . The system of  claim 7  wherein the sustained release device is attached to the orthopedic hardware component using an interference fit.  
     
     
         12 . The system of  claim 7  wherein the sustained release device includes a first suture eye and the orthopedic hardware component includes a second suture eye, the sustained release device being attached to the orthopedic hardware component using a suture through each of the first suture eye and the second suture eye.  
     
     
         13 . The system of  claim 7 , the orthopedic hardware component including a chamber, the sustained release device configured for placement in the chamber of the orthopedic hardware component.  
     
     
         14 . The system of  claim 1  wherein the sustained release device is integrally formed with the orthopedic hardware component.  
     
     
         15 . The system of  claim 1  wherein the compound is a low-solubility compound.  
     
     
         16 . The system of  claim 15  wherein the compound comprises a matrix of an effective agent and a polymer that is permeable to the effective agent.  
     
     
         17 . The system of  claim 15  wherein the sustained release device includes an inner core containing the compound, the sustained release device further comprising a non- bioerodible polymer coating layer, the non-bioerodible polymer coating layer being permeable to the compound, wherein the non-bioerodible polymer coating layer covers the inner core and is essentially non-release rate limiting.  
     
     
         18 . The system of  claim 1  wherein the compound comprises a soluble compound.  
     
     
         19 . The system of  claim 18  wherein the compound is surrounded by an outer layer that covers the compound and includes a first surface and a second surface, the first surface being substantially impermeable to the compound and the second surface being permeable to the compound and limiting a release rate of the compound.  
     
     
         20 . The system of  claim 1 , the compound including at least one of a steroid, an antibiotic, an anti-inflammatory drug, an antiproliferative compound, an antimyotic compound, an antimitotic compound, an antimetabolite compound, a pain-relieving drug, a corticosteroid, an angiostatic steroid, a non-steroidal anti-inflammatory agent, or a co-drug.  
     
     
         21 . The system of  claim 1 , the therapeutic effect including at least one of an anti- inflammatory effect, a pain-relief effect, an anesthetic effect, an immune suppressant effect, an antibiotic effect, an anti-viral effect, a cancer-fighting effect, an anti-cancer effect, an anti-proliferative effect, a cartilage-protecting effect, or an anti-scarring effect.  
     
     
         22 . A system comprising: 
 a hardware means for forming an attachment to a bone of a body;    a drug delivery means for providing sustained release of a drug; and    an attachment means for attaching the drug delivery means to the hardware means.    
     
     
         23 . A method comprising: 
 attaching an orthopedic hardware component to a portion of a body;    providing a compound having a therapeutic effect;    associating the compound with the orthopedic hardware component; and releasing the compound over an extended period of time.    
     
     
         24 . The method of  claim 23  wherein attaching the orthopedic hardware component further comprises screwing the component into a bone of the body;  
     
     
         25 . The method of  claim 23  wherein attaching the orthopedic hardware component further comprises driving a pin into a bone of the body;  
     
     
         26 . The method of  claim 23  wherein attaching the orthopedic hardware component further comprises suturing the component to a soft tissue of the body.  
     
     
         27 . The method of  claim 23  wherein the orthopedic hardware component includes at least one of a staple, a tack, a dart, a bolt, a washer, a plate, a prosthetic joint, a component of a prosthetic joint, an anchor, a pin, a wire, or a button.  
     
     
         28 . The method of  claim 23  wherein associating the compound with the orthopedic hardware component further comprises removably attaching a sustained release device that includes the compound to the orthopedic hardware component using at least one of threads that rotatably engage the sustained release device to the orthopedic hardware component, an interference fit between the sustained release device and the orthopedic hardware component, a pin passing through the orthopedic hardware component and the sustained release device, or a suture passing between a suture eye of each one of the orthopedic hardware component and the sustained release device.  
     
     
         29 . The method of  claim 23  wherein the compound is a low-solubility compound, releasing the compound further comprising exposing the compound to a bodily fluid such that the compound dissolves into the bodily fluid.  
     
     
         30 . The method of  claim 23  wherein the compound is a high-solubility compound, releasing the compound further comprising exposing the compound to a bodily fluid through a membrane that limits a rate of release of the compound.  
     
     
         31 . The method of  claim 23  wherein the compound includes at least one of a steroid, an antibiotic, an anti-inflammatory drug, an antiproliferative compound, an antimyotic compound, an antimitotic compound, an antimetabolite compound, a pain-relieving drug, a corticosteroid, an angiostatic steroid, a non-steroidal anti-inflammatory agent, or a co-drug.  
     
     
         32 . The method of  claim 23  wherein the therapeutic effect includes at least one of an anti-inflammatory effect, a pain-relief effect, an anesthetic effect, an immune suppressant effect, an antibiotic effect, an anti-viral effect, a cancer-fighting effect, an anti-cancer effect, an anti-proliferative effect, a cartilage-protecting effect, or an anti-scarring effect.  
     
     
         33 . The method of  claim 23  wherein attaching the orthopedic hardware component comprises attaching the component within a synovial capsule of a joint, the compound including one or more treatments for at least one of osteoarthritis or rheumatoid arthritis.

Join the waitlist — get patent alerts

Track US2005031665A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.